---
layout: page
---

<div class="row content">
<h1>Publications</h1>
<p>Hellerstein, D. J., <u>Batchelder</u>, S. T., Hyler, S.E., Arnaout, B., Toba, C., Benga, I., &amp; Gangure, D.  (2010). Escitalopram versus placebo in the treatment of dysthymic disorder.  <i>International Clinical Psychopharmacology</i>, 25, 143-148. doi: <a href="http://psycnet.apa.org/doi/10.1097/YIC.0b013e328333c35e" target="_blank">10.1097/YIC.0b013e328333c35e</a></p>
<p>Cohen, L. R., Hien, D. A., &amp; <u>Batchelder</u>, S. T. (2008). The Impact of Cumulative Maternal Trauma and Diagnosis on Parenting Behavior. <i>Child Maltreatment, 13</i>(1), 7-38. doi: <a href="http://psycnet.apa.org/doi/10.1177/1077559507310045" target="_blank">10.1177/1077559507310045</a></p>
<p>Hellerstein, D. J., <u>Batchelder,</u> S. T.; Hyler, S. E., Arnaout, B., Corpuz, V., Coram, L., &amp; Weiss, G. (2008). Aripiprazole as an adjunctive treatment for refractory unipolar depression. <i>Progress in Neuro-Psychopharmacology &amp; Biological Psychiatry</i>, <i>32</i>, 744-750. doi: <a href="http://psycnet.apa.org/doi/10.1016/j.pnpbp.2007.11.024" target="_blank">10.1016/j.pnpbp.2007.11.024</a></p>
<p>Arnaout, B., <u>Batchelder,</u> S., Rosenthal R. N., Hyler S. E., Hellerstein, D. J. (2008). <a name="906661330"/><a href="http://www.informaworld.com/smpp/content~content=a906661330~db=all~order=page" target="_top">Does a history of alcohol use disorder affect response to antidepressant medication in patients with dysthymic disorder?</a> <strong><i>Journal of Dual Diagnosis, 4, </i></strong><a href="http://www.informaworld.com/smpp/content~content=a906661330~db=all~order=page" target="_top">377–393</a>.</p>
<p><em>Hellerstein, D. J., Seirmarco, G., Almeida, G., &amp; Batchelder, S. (2008). Assessing behavioral coping preferences of psychiatric inpatients: A pilot study.  </em><i>Medscape Journal of Medicine,</i><i> </i><i>10(12), 271.</i></p>
<p>Hyler, S. E., Gangure,  D. P., &amp; <u>Batchelder,  S. T.</u> (2005) Can telepsychiatry replace in-person psychiatric assessments? A review and meta-analysis of comparison studies. <i>CNS Spectrums 10</i>, 403-413.</p>
<p>Hellerstein, D. J., <u>Batchelder, S.,</u> Miozzo, R., Kreditor, D., Hyler, S., Gangure, D., &amp; Clark J. (2004). Citalopram in the treatment of dysthymic disorder.<i> International Clinical Psychopharmacology,</i> <i>19,</i> 143-148.</p>
<p>Hellerstein, D.J., <u>Batchelder, S.</u>, Lee, A., Borisovaskaya, M. (2002). Rating dysthymia: An assessment of the construct and content validity of the Cornell Dysthymia Rating Scale. <i>Journal of Affective Disorders, 71</i>, 85-96.</p>
<p>Hellerstein, D.J., <u>Batchelder, S.</u>, Kreditor, D., Fedak, M. (2001). Bupropion Sustained Release in the treatment of dysthymic disorder: An open-label study. <i>Journal of Clinical Psychopharmacology, 21</i>, 325-329. </p>
<p>Hellerstein, D.J., Little, S.A.S., Samstag, L.W., <u>Batchelder, S.</u>, Muran, J.C., Fedak, M., Kreditor, D., Rosenthal, R.N., Winston, A. (2001). Combined medication and group psychotherapy in dysthymia: a randomized prospective pilot study. <i>Journal of Psychotherapy Practice and Research, 10</i>, 93-103.</p>
<p>Hellerstein, D.J., <u>Batchelder, S.T.</u>, Little, S.A.S., Fedak, M.J., Kreditor, D., Rosenthal, J.  (1999). Venlafaxine in the treatment of dysthymia: An open-label study.  <i>Journal of Clinical Psychiatry, 60</i>, 845-849.</p>
<p>Gutkovich, Z., Rosenthal, R. N., Galynker, I., Muran, J.C., <u>Batchelder, S. T.</u>, &amp; Itskhoki, E. (1999). Depression and demoralization among Russian-Jewish immigrants in primary care. <i>Psychosomatics, 40, </i>117-125.</p>
<p>Samstag, L.W., <u>Batchelder, S.T.</u>, Muran, J.C., Safran, J.D. &amp; Winston, A.  (1998).  Early identification of treatment failures in short-term psychotherapy: An assessment of self-reported therapeutic alliance and interpersonal behavior.  <i>Journal of Psychotherapy Research and Practice, 7</i>, 126-143.  </p>
<p>Hellerstein, D.J., Little, S.A.S., <u>Batchelder, S.</u>, Samstag, L.W., Rosenthal, R.N., Winton, A. (1997).  Dysthymia: An outcome study of combined group therapy and medication treatment vs. medication treatment alone, <i>New Research Programs and Abstracts,</i> American Psychiatric Association, San Diego, 176-177.</p>
<p>Muran, J.C., Wallner, L., Jilton, R., <u>Batchelder</u>, S., Winston, A.  (1997). Development of a suboutcome strategy to measure interpersonal process in psychotherapy from an observer perspective.  <i>Journal of Clinical Psychology, 53,</i> 405-420.</p>

<h1>Presentations</h1>
<p>Bullitt, C., <u>Batchelder</u>, S.T., &amp; McCullough, L.  Intensive content and process analysis of the composition of transference interpretations and the effects of outcome. In H.F.A. Azim, (moderator<i>)   The use and impact of transference interpretations in dynamically-oriented psychotherapy.</i>  Panel  session at the annual meeting of the Society for Psychotherapy Research, Wintergreen, Virginia, (1990, June).</p>
<p><u>Batchelder</u>, S.T., Pollack, J., &amp; McCullough, L. Sequential analyses of therapeutic interactions involving transference interpretations.  In A. Winston (moderator), <i>The Beth Israel Brief Psychotherapy Research Project.</i>  Panel conducted at the annual convention of the Society for Psychotherapy Research, <place><city>Lyon</city>, <country-region>France</country-region></place>.  (1991, July). </p>
<p>Muran, J.C., Wallner, L., Jilton, R., <u>Batchelder</u>, S.T. &amp; Winston, A.  Relationship of patient-therapist interpersonal transactions to the therapeutic alliance within session and across treatment.  In A. Winston (Moderator), <i>The therapeutic relationship - Beth Israel Brief Psychotherapy Research Project.</i> Panel conducted at the annual convention of the Society for Psychotherapy Research, <place><city>Berkeley</city>, <state>CA</state></place>.  (1992, June). </p>
<p>Jilton, R., <u>Batchelder</u>, S.T., Muran, J.C., Gorman, B., Safran, J.D., Samstag, L.W., &amp; Winston, A. Content analysis of therapeutic alliance rupture events.  In A.Winston (Chair), <i>Ruptures in the therapeutic alliance I:  Assessment.</i>  Symposium conducted at the annual meeting of the Society for Psychotherapy Research, <place><city>York</city>, <country-region>England</country-region></place>.  (1994, June). </p>
<p><u>Batchelder</u>, S.T., Jilton, R., Safran, J. &amp; Muran, J.C.  An application of interpersonal process recall to alliance rupture resolution events.  In J.D. Safran (Chair), <i>Ruptures in the therapeutic alliance II: Treatment.</i>  Symposium conducted at the annual meeting of the Society for Psychotherapy Research, <place><city>York</city>, <country-region>England</country-region></place>.  (1994, June). </p>
<p>Samstag, L.W., <u>Batchelder</u>, S.T., Muran, J.C., Safran, J.D., &amp; Winston, A.  In-treatment predictors of psychotherapy outcome. In A. Winston (chair), <i>Treatment failures in brief psychotherapy.</i>  Symposium conducted at the annual meeting of the American Psychiatric Association, <place><city>Philadelphia</city>, <state>PA.</state></place>  (1994, May).</p>
<p><u>Batchelder</u>, S.T., Jilton, R., Safran, J. &amp; Muran, J.C.  Retrospective analysis of problem resolution.  In A. Winston (chair), <i>Treatment failures in brief psychotherapy.</i>  Symposium conducted at the annual meeting of the American Psychiatric Association, <place><city>Philadelphia</city>, <state>PA.</state></place>   (1994, May). </p>
<p>Samstag, L.W., <u>Batchelder</u>, S.T., Muran, J.C., Safran, J.D., Bernbach, E., and Winston, A.  Difficult dyads: Evolution of a system for assessing interpersonal process and predicting treatment failure.  In A. Winston (Chair), <i>Resolving problems in the therapeutic alliance.</i>  Symposium conducted at the annual meeting of the Society for Psychotherapy Research, <place><city>Vancouver</city>, <country-region>Canada</country-region></place>.  (June 1995). </p>
<p>Jilton, R., <u>Batchelder</u>, S.T., Muran, J.C., Gorman, B., Safran, J., &amp; Winston, A.   How the  patient sees problems in the alliance: A second look at types of rupture events.   In A. Winston  (Chair), <i>Resolving problems in the therapeutic alliance.</i>  Symposium conducted at the annual meeting of the Society for Psychotherapy Research, <place><city>Vancouver</city>, <country-region>Canada</country-region></place>.  (June 1995). </p>
<p>Hellerstein, D.J., Little, S.A.S., <u>Batchelder,</u> S., Samstag, L.W., Rosenthal, R.N., Winston, A., "Dysthymia: an outcome study of combined group therapy and medication treatment vs. medication treatment alone," Paper presented at the American Psychiatric Association, <city><place>San Diego</place></city>, CA. (May 1997).</p>
<p>Gutkavich, Z., Rosenthal, R.N., Muran, J.C., Galynker, <place>I.</place>, <u>Batchelder</u>, S.T., &amp; Itskhoki, E. “Depression and demoralization among Russian-Jewish émigrés in primary care.”  Paper presented at the annual meeting of the <place><placetype>Academy</placetype> of <placename>Psychosomatic Medicine</placename></place>, <place><city>Coronado</city>, <state>CA</state></place>.   (November 1997).  </p>
<p>Borisovaskaya, M., Hellerstein, D.J., <u>Batchelder, S.</u>, Lee, A., “Assessing dysthymia using the Cornell Dysthymia Rating Scale.” Presented at the American Psychiatric Association Annual Meeting, <place><city>Washington</city> <state>DC</state></place>. (May 1999).</p>
<p><u>Batchelder, S.T.</u> “Case presentation.”  In Doctors, S.R., Kindler, A., &amp; Batchelder, S.T. </p>
<p>Master Class, Presented at the International Conference on the Psychology of the Self, Chicago, IL, USA. (November, 2006).</p>
<p><u>Batchelder, S. T.</u> “Why should I trust you?: The intersubjective erosion of mistrust.”<i> </i>Paper presented at<i> New York Meets Vienna</i>, IPSS-WKSP Spring Meeting, New York, NY (April, 2011).</p>

<h1>Posters</h1>
<p>Hellerstein, D.J., <u>Batchelder, S.</u>, Little, S.A.S., Fedak, M., Kreditor, D. “Venlafaxine in the treatment of dysthymia: An open-label study.”  New Clinical Drug Evaluation Unit, National Institute of Mental Health, <place><city>Boca Raton</city>, <state>Fla.</state></place> (June, 1999).</p>
<p>Hellerstein, D.J., <u>Batchelder, S.</u>, Kreditor, D., Fedak, M.. “Bupropion SR in dysthymic disorder.” New Clinical Drug Evaluation Unit, National Institute of Mental Health, <place><city>Boca Raton</city>, <state>Fla.</state></place> (June 1999).</p>
<p>Hellerstein D.J., <u>Batchelder, S.</u>, Kreditor, D., &amp; Fedak, M. “Bupropion SR in the treatment of dysthymic disorder: An open-label study." American Psychiatric Association Annual Meeting, Chicago, (May, 2000).</p>
<p>Miozzo, R., <u>Batchelder, S.</u>, Tisminetzsky, M., &amp; Hellerstein, D. J. “Analysis of Hamilton Rating Scale for Depression scores in patients with Dysthymic Disorder.” American Psychiatric Association Annual Meeting, New York, (May, 2004).</p>
<p>Toba, C., Hellerstein, D. J., <u>Batchelder, S.</u>, Meresh, E., &amp; Hyler, S. Comorbidity of anxiety disorders in dysthymic disorder. American Psychiatric Association Annual Meeting, New York, (May, 2004).</p>
<p>Benga, I., Hellerstein, D. J., <u>Batchelder, S. T.</u>, &amp; Hyler, S. E. “Suicidal ideation during antidepressant treatment of dysthymic disorder.” New Research Abstracts, American Psychiatric Association Annual Meeting, Atlanta (May, 2005).</p>
<p>Arnaout, B., <u>Batchelder, S. T.</u>, Hyler, S. E., &amp; Hellerstein, D. J. “Does a history of alcohol use disorder affect response to antidepressant medication in patients with dysthymic disorder?” American Psychiatric Association Annual Meeting, Toronto (May, 2006).</p>
</div>
